Académique Documents
Professionnel Documents
Culture Documents
-agonists
for comorbid symptoms: TCA, neuroleptics, clonidine, lithium, MAOI, carbamazepine
Conduct Disorder (CD)
prevalence
males: 6-16%, females 2-9%
M:F = 4-12:1
etiology
parental/familial factors
parental psychopathology (e.g. ASPD, substance abuse)
child rearing practices (e.g. child abuse, discipline)
low SES, family violence
child factors - difficult temperament, ODD, learning problems, neurobiology
PS34 Psychiatry MCCQE 2006 Review Notes
CHILD PSYCHIATRY . . . CONT.
diagnosis
persistent behavioural pattern in which others basic rights/societal norms are violated
categories of violation include:
aggression to people/animals
property destruction
deceitfulness/theft
serious rule violation
the disturbance causes clinically significant impairment in social,
academic, or occupational functioning.
if individual is 18 years or older, criteria not met for ASPD
diagnostic types (associated features)
childhood onset - ODD, aggressive, impulsive, poor prognosis
adolescent onset - less aggressive, gang-related delinquency, better prognosis
poor prognostic indicators: early-age onset, high frequency and
variety of behaviours, pervasive (i.e. home, school, and community)
vs. situational disorder, comorbid ADHD, early sexual activity/substance abuse
50% of CD children become adult ASPD
treatment
early intervention necessary and more effective
parent management training, anger replacement training, CBT,
family therapy, education/employment programs, social skills
training, medications (e.g. carbamazepine) for aggressivity or
comorbid disorder
Oppositional Defiant Disorder (ODD)
prevalence: 2-16%
diagnosis
A. a pattern of negativistic, hostile, defiant, disobedient behaviour
towards parental/authority figures over a 6 month period (i.e. loses
temper often, violates minor rules, argumentative, etc.)
B. behaviour causes significant impairment in social, academic or
occupational functioning
C. behaviours do not occur exclusively during the course of a psychotic or mood disorder
D. criteria not met for CD; if 18 years or older, criteria not met for ASPD
features that typically differentiate ODD from transient
developmental stage: onset at 8 years old; chronic duration
(> 6 months); frequent intrusive behaviour
impact of behaviour: poor school performance, few friends, strained
parent/child relationships
course: may progress to conduct disorder
treatment (goal is to establish generational boundary): parent
management training, individual/family psychotherapy
TIC DISORDERS
four types: Tourettes disorder, chronic motor/vocal tic disorder,
transient tic disorder, tic disorder not otherwise specified (NOS)
tics: involuntary, sudden, rapid, recurrent, nonrhythmic,
stereotyped motor movements or vocalizations
simple tics - eye blinking, nose wrinkling, facial grimacing, shoulder shrugging
complex tics hand gestures, jumping, touching, facial contortions, coprolalia
Tourettes Disorder
epidemiology
prevalence 4-5 per 10,000
M:F = 3:1
onset: motor - age 7, vocal - age 11
etiology
genetic
MZ > DZ twins, autosomal dominant
Tourettes and chronic tic disorder aggregate within same families
dopamine serotonin dysregulation
diagnosis
A. multiple motor tics and at least one vocal tic
B. tics occur many times a day, nearly every day for 1 year without a
tic-free period of more than 3 consecutive months
C. onset before 18 years
D. disturbance not due to direct physiological effects of substance or GMC
presentation
50% initial tic = eyeblinking; others include head jerking, facial grimace, tongue protrusion, etc.
vocal tics can include sniffing, coughing, throat clearing (rule out ENT problem)
course
social, academic, occupational impairment due to rejection by peers; anxiety about tics in
social situations
chronic and life-long with periods of remission and exacerbations
MCCQE 2006 Review Notes Psychiatry PS35
CHILD PSYCHIATRY . . . CONT.
treatment
behavioural therapy, psychotherapy for both family and individual;
important to address relation of stress to the disorder
for tics - atypical neuroleptics,